BDNF and proBDNF Serum Protein Levels in Obstructive Sleep Apnea Patients and Their Involvement in Insomnia and Depression Symptoms

Abstract

Introduction: Obstructive sleep apnea (OSA) is a disorder that, apart from somatic sequelae, increases the risk of developing psychiatric conditions. Brain-derived neurotrophic factor (BDNF) signaling pathway is involved in the pathophysiology of depression and insomnia. Therefore, the study aimed to investigate differences in concentrations of BDNF and proBDNF in patients with OSA and healthy individuals, to evaluate diurnal changes of these proteins, and to assess the correlations with psychiatric symptoms. Methods: Sixty individuals following polysomnography (PSG) were divided into two groups based on the apnea-hypopnea index (AHI): OSA patients (AHI ≥ 30; n = 30) and control group (AHI < 5; n = 30). Participants filled out questionnaires: Beck Depression Inventory (BDI), Athens Insomnia Scale (AIS), and Pittsburgh Sleep Quality Index (PSQI). Peripheral blood was collected before and after PSG. Protein concentrations were measured using ELISA. OSA group was divided into subgroups: AIS (−)/AIS (+) (AIS > 5), PSQI (−)/PSQI (+) (PSQI > 5), and BDI (−)/BDI (+) (BDI > 19). Results: No differences in BDNF and proBDNF protein levels were observed between OSA and the control groups. However, BDNF and proBDNF evening protein concentrations were higher in the AIS (+) and PSQI (+) groups (p < 0.001 for all). The BDI (+) group was characterized by lower morning levels of both proteins (p = 0.047 and p = 0.003, respectively). Conclusions: BDNF signaling pathway might be involved in the pathophysiology of depression and insomnia in patients with OSA. BDNF and proBDNF protein levels might be useful in defining OSA phenotypes.

Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea

“…The proBDNF, a derived product of BDNF, relates to age and HIF-1α morning quantity [ 74 ]. BDNF and proBDNF evening concentrations are higher in patients with alteration measured with the Athens Insomnia Scale (AIS), Pittsburg Sleep Quality Index (PSQUI) positive, and lower in those with Beck Depression Inventory (BDI) positive [ 75 ]. There is also a correlation between plasmatic BDNF levels and the oxygen desaturation index, and a negative one with the AHI.…”

Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease

“…In another study on subjects with obstructive sleep apnea (OSA), higher serum BDNF was associated with increased ESS score [ 43 ]. Moreover, OSA subjects with more pronounced insomnia symptoms and impaired sleep quality were shown to have lower evening level of serum BDNF and proBDNF [ 44 ]. However, as Santiago et al found, not BDNF but cortisol awakening response bears a closer relation to sleep quality [ 45 ].…”

Relation between symptoms of insomnia, depression, sleep quality, anti-tumor necrosis factor therapy and disrupted circadian clock genes’ expression in inflammatory bowel disease

“…The lesser -known mechanism driving the psychiatric aspect of IBD is related to neurotrophins, in particular brain -derived neurotrophic factor (BDNF). 5 This protein and its precursor, proBDNF, exert a pleiotropic effect on the organism, mediating the interactions between the central nervous system and the periphery. 6, 7 Circadian rhythm has been gaining notoriety as a factor in developing immune -mediated diseases and psychiatric comorbidities on a molecular level.…”